Bristol-Myers Squibb (BMY) Agrees to Acquire ZymoGenetics (ZGEN) for $9.75/Share
Tweet Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) enters agreement to acquire ZymoGenetics, Inc. (NASDAQ: ZGEN) for $9.75 per share in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
